Health & Biotech
Health & Biotech
Volpara shares gain on $23m acquisition of breast-cancer risk assessment company
Health & Biotech
Blood cancer is becoming a big killer but there are only a handful of ASX stocks fighting it
Health & Biotech
Osteopore inks partnership with US blood technology company
Health & Biotech
Creso Pharma cheers as Australia allows over-the-counter CBD oil sales
Health & Biotech
Oneview Healthcare shares rise nearly 90pc following a Samsung distribution agreement
Health & Biotech
Dr Boreham’s Crucible: Orthocell’s got some nerve… and FDA, TGA and CE approval
Health & Biotech
Creso Pharma reports rapid growth in fourth quarter with 740% increase in sales
Health & Biotech
Aged care AI company InteliCare saw distributors increase by almost half in the December quarter
Health & Biotech
Dimerix planning longer study of DMX-200 to treat kidney disease
Health & Biotech
Clinical Trials Tracker: 2022 and beyond
Health & Biotech
Nutritional Growth Solutions partners with global entertainment company to spearhead growth in Asia
Health & Biotech
Eve Investments reports record quarter boosted by Amazon online sales
Health & Biotech
Your ultimate guide to ASX pet stocks
Health & Biotech
WA Cannabis stock Little Green Pharma chosen to supply a significant French medical cannabis trial
Health & Biotech
Immutep Covid-19 trial moves forward in Czech Republic
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.